🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The power of the intestine against metastases - new article from AYYOUB LAB CRCT-Oncopole published in Science Immunology ➡️crct-inserm.fr/en/the-power-o…

Le pouvoir de l’intestin contre les métastases. Nouvel article de l'équipe AYYOUB LAB du CRCT-Oncopole publiée dans la revue Science Immunology ➡️crct-inserm.fr/le-pouvoir-de-…

Thank you for highlighting our work Science Immunology Devaud Christel AYYOUB LAB

New studies in Science & Science Immunology spotlight a group of intestinal T cells with α4β7 integrin receptors that could be targeted to prevent resistance to immune checkpoint blockade #cancer immunotherapy. scim.ag/2ZC scim.ag/2ZD scim.ag/2ZB

Thank you Science Magazine for the fascinating perspective highlighting the central role of intestinal T cells in systemic cancer immune surveillance 👌 Virginie Feliu AYYOUB LAB Science Immunology

Découverte majeure à l'Oncopole de Toulouse : le côlon pourrait contrer les métastases grâce aux lymphocytes T CD8 antitumoraux, capables spontanément de contrôler la croissance de la tumeur primaire mais aussi de métastases à distance, en particulier hépatiques. ⤵️⤵️

A new Science Immunology study investigates how intestinal α4β7+ CD8 T cells enhance immune responses against metastatic tumors typically resistant to anti-PD-L1 immunotherapy. 📄: scim.ag/305

Congratulations Jonathan Khalifa 🎗️ 👏

Read the interview of Devaud Christel & Virginie Feliu in ACIR highlighting their findings published in Science Immunology It's about tumor immunology & more 🤔 acir.org/weekly-digests…

New immune checkpoint affected by the gut #microbiome involved in lack of #immunotherapy responses in colon cancer. Read our double feature here: bit.ly/3NDvawe Virginie Feliu Devaud Christel AYYOUB LAB  Gustave Roussy  Carolina Alves Costa Silva, MD, PhD  lisaderosa #CRCSM

Check out this new Science Immunology paper! A team at Université de Toulouse showed how a subset of #Tcells from colon tumors improves control of liver tumors. Virginie Feliu Carlos Gomez-Roca Devaud Christel 📰 bit.ly/3NG3syN 🎧 bit.ly/3qSkalF

[communiqué de presse CRCT] Cancer : un mécanisme clé pour améliorer les immunothérapies identifié par une équipe toulousaine. Article publié dans le journal Immunity par l'équipe GENIM du CRCT-Oncopole ➡️crct-inserm.fr/cancer-un-meca…

Happy to share with you our recent findings @CRCTOncopole @inserm on the TCR independent role of the activating receptor CD137 on T cell exhaustion published in Immunity. #Immunotherapy #CancerResearch. cell.com/immunity/pdf/S…

Thank you Cancer Discovery for the research watch about our works, Devaud Christel AYYOUB LAB IUCT Oncopole CRCT-Oncopole α4β7-Positive T Cells Mediate Responses to Cancer Immunotherapy …rnals-org.proxy.insermbiblio.inist.fr/cancerdiscover…

Thanks EACR for your highlight (#8) EACR Highlights in Cancer Research: August 2023 magazine.eacr.org/highlights-in-… via EACR

Des chercheuses révèlent comment notre côlon lutte contre le cancer colorectal : vers des thérapies ciblées et un potentiel vaccin france3-regions.francetvinfo.fr/occitanie/haut… Devaud Christel AYYOUB LAB IUCT Oncopole CRCT-Oncopole

lemonde.fr/international/…

Congratulation at Clara Maria Scarlata from CRCT-Oncopole who receive a best oral communication price delivered by IntegraGen at the the 1st young cancer researchers congress (#YS2C_GSO)

Une jeune chercheuse toulousaine soutenue pour ses travaux en cancérologie sur les cellules "super-tueuses" ladepeche.fr/2024/02/07/une… via La Dépêche du Midi